Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study

AIM: Cysteinyl leukotrienes receptor antagonists (LTRAs) are promising chemoprevention options to target cysteinyl leukotriene signaling in cancer. However, only a number of randomized clinical trials (RCTs) or observational studies have been conducted to date; thus, the effect of LTRAs on patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Ha Young, Kim, In-Wha, Oh, Jung Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021999/
https://www.ncbi.nlm.nih.gov/pubmed/35463337
http://dx.doi.org/10.3389/fonc.2022.858855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021999/
https://www.ncbi.nlm.nih.gov/pubmed/35463337
http://dx.doi.org/10.3389/fonc.2022.858855

Ejemplares similares